chartexchange

PRAX
Praxis Precision Medicines, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
305.10USD+0.013%(+0.04)425,752
After-hoursNov 18, 2026 4:18:30 PM EST
306.50USD+0.459%(+1.40)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Boston, MA, USA
Previous Close
$305.06
Beta
1.62
52-Week High
$392.70 2026-08-20
52-Week Low
$160.11 2025-11-21
SMA 50
$288.12
SMA 200
$314.54
Avg. Vol 10D
587,855
Avg. Vol 30D
533,518
Avg. Vol 90D
449,135
Relative Vol
0.80
24.11M
0.2700%
2,525
Feb 25, 2027 (98d)
Nov 29, 2023 · 1-for-15 (reverse)
PRAX Profile

praxis precision medicines, inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. its lead product candidates include prax-114, an extrasynaptic-preferring gabaa receptor positive allosteric modulator that is in phase iia clinical trial for the treatment of major depressive disorder and perimenopausal depression; and prax-944, a selective small molecule inhibitor of t-type calcium channels, which is in phase iia clinical trial for the treatment of essential tremor. the company is also developing prax-562, a persistent sodium current blocker that is in phase i clinical trial to treat severe pediatric epilepsy and adult cephalgia; prax-222, an antisense oligonucleotide for patients with gain-of-function (gof) scn2a epilepsy; and kcnt1 program for the treatment of kcnt1 gof epilepsy. it has a cooperation and license agreement with rogcon inc.; a license agreement purdue neuroscience company; and a res

PRAX Performance
PeriodPriceDateChangeBeta
1W346.212026-11-11-11.94%1.688
1M260.172026-10-19+17.18%2.871
3M369.842026-08-18-17.57%2.388
6M320.532026-05-18-4.89%1.569
1Y184.132025-11-18+65.57%1.624
2Y71.512024-11-18+326.32%—
5Y281.702021-11-18+8.22%1.035
PRAX Stock Summary

Praxis Precision Medicines, Inc. Common Stock (NASDAQ:PRAX) stock price today is $304.86, and today's volume is 425,752. PRAX is down 0.066% today. The 30 day average volume is 533,518. PRAX market cap is $8.52B with 27.95M shares outstanding.